FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
DIAGNOSTIC PRODUCTS CORP [ DP ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 07/27/2006 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 07/27/2006 | D | 55,139(1) | D | (2) | 0 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Common Stock Option - Right to Buy | $23.75 | 07/27/2006 | D | 6,667 | 01/08/2004 | 01/08/2011 | Common Stock | 6,667 | (3) | 0 | D | ||||
Common Stock Option - Right to Buy | $42.7 | 07/27/2006 | D | 10,000 | (4) | 01/02/2012 | Common Stock | 10,000 | (3) | 0 | D | ||||
Common Stock Option - Right to Buy | $38.68 | 07/27/2006 | D | 10,000 | (5) | 01/06/2013 | Common Stock | 10,000 | (3) | 0 | D | ||||
Common Stock Option - Right to Buy | $45.89 | 07/27/2006 | D | 10,000 | (6) | 01/05/2014 | Common Stock | 10,000 | (3) | 0 | D | ||||
Common Stock Option - Right to Buy | $53.92 | 07/27/2006 | D | 10,000 | (7) | 01/04/2015 | Common Stock | 10,000 | (3) | 0 | D | ||||
Common Stock Option - Right to Buy | $48.73 | 07/27/2006 | D | 5,000 | (8) | 02/15/2013 | Common Stock | 5,000 | (3) | 0 | D |
Explanation of Responses: |
1. Represents shares held outright. |
2. Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 26, 2006, by and among the issuer, Siemens Medical Solutions USA, Inc., and Dresden Acquisition Corporation (the "Merger Agreement") in exchange for $58.50 in cash for each share of common stock of the issuer owned. |
3. Cancelled pursuant to the Merger Agreement in exchange for an amount equal to $58.50 for each share of common stock of the issuer subject to the cancelled option, less the applicable exercise price and any applicable withholding taxes, the aggregate amount of which is payable in the form of cash. |
4. 3,334 vested on January 2, 2003 and 3,333 vested on each of January 2, 2004 and January 2, 2005. |
5. 3,334 vested on January 6, 2004 and 3,333 vested on each of January 6, 2005 and January 6, 2006. |
6. 3,334 vested on January 5, 2005 and 3,333 vested on January 5, 2006. The remaining 3,333 will vest on January 5, 2007. |
7. 3,334 vested on January 4, 2006. 3,333 will vest annually on January 4, 2007 through January 4, 2008. |
8. 1,667 will vest on February 15, 2007, 1,666 will vest on February 15, 2008 and 1,667 will vest on February 15, 2009. |
James L. Brill, Authorized Signer | 07/27/2006 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |